Recent advances in cancer diagnosis with nuclear medicine techniques.
Recent progress in cancer detection in nuclear medicine has been significant and encouraging. Three main trends are responsible. First, techniques of imaging have improved, often in conjunction with the development of new and better imaging devices. Secondly, new radiopharmaceuticals are being investigated. Finally, interaction with other imaging modalities has started. In general, this yields complementary information further refining the diagnostic process.
D000912:Antibodies, Neoplasm; D001761:Bleomycin; D001859:Bone Neoplasms / Q000175:diagnosis; D001932:Brain Neoplasms / Q000175:diagnosis; D003037:Cobalt Radioisotopes; D005710:Gallium Radioisotopes; D006801:Humans; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009369:Neoplasms / Q000175:diagnosis*; D011877:Radionuclide Imaging / Q000295:instrumentation; D013964:Thyroid Neoplasms / Q000175:diagnosis; D014057:Tomography, X-Ray Computed
D000912:Antibodies, Neoplasm; D003037:Cobalt Radioisotopes; D005710:Gallium Radioisotopes; D001761:Bleomycin